截至2026年5月29日14:05,港股通生物科技ETF华安(159102)上涨3.29%,成分股信达生物上涨11.89%,三生制药上涨9.22%,映恩生物-B上涨8.99%,康方生物,石药集团等个股跟涨。 消息面上,信达生物在港交所公告,公司连同其附属公司信达生物制药有限公司及FortvitaBiologics(USA),Inc.与辉瑞公司,就12个具有突破性潜力的肿瘤早期及源头创新研发项目...
Source Link截至2026年5月29日14:05,港股通生物科技ETF华安(159102)上涨3.29%,成分股信达生物上涨11.89%,三生制药上涨9.22%,映恩生物-B上涨8.99%,康方生物,石药集团等个股跟涨。 消息面上,信达生物在港交所公告,公司连同其附属公司信达生物制药有限公司及FortvitaBiologics(USA),Inc.与辉瑞公司,就12个具有突破性潜力的肿瘤早期及源头创新研发项目...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.